OG
Organon
OGN·NYSEJersey City NJFounded 20219,000 employees
Mid CappharmaPublicWomen's HealthOncology
Platform: Women's Health
Market Cap
$5B
All Drugs
3
Clinical Trials
6
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (OGN)
Loading OGN stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| OGN-4949 | OGN-4949 | Phase 1/2 | 2 | EZH2 | Urothelial Ca | ||
| Gelizasiran | OGN-7097 | Phase 2/3 | 2 | CDK2 | ThymomaFSGS | ||
| OGN-5336 | OGN-5336 | Phase 1 | 2 | IL-13 | MigraineCKD |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)